AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$42.57 USD
-0.06 (-0.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $42.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$42.57 USD
-0.06 (-0.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $42.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Veeva (VEEV) Beats on Q4 Earnings, Narrows '23 Revenue View
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q4 results reflect impressive performances by both of its segments.
Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat
by Zacks Equity Research
Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
by Zacks Equity Research
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.
Masimo's (MASI) SedLine Receives FDA's Pediatric Indication
by Zacks Equity Research
The latest FDA clearance for Masimo's (MASI) SedLine is likely to improve brain function monitoring in pediatric patients.
Insulet (PODD) Product Volume Up, COVID-Led Softness Persists
by Zacks Equity Research
Insulet's (PODD) drug delivery revenues surge led by increased production volumes, driven by higher-than-expected demand from its partner.
Henry Schein (HSIC) Expands Data Analytics to Private Practices
by Zacks Equity Research
Henry Schein's (HSIC) introduction of Jarvis Analytics for Private Practices offers practice owners a simple, powerful tool to help improve practice success through data-driven decisions.
Alcon (ALC) Surgical Arm Expands, International Growth Slows
by Zacks Equity Research
In Surgical, Alcon (ALC) remains the market leader in presbyopia correcting IOLs on the strength of both PanOptix and Vivity.
Medtronic's (MDT) NuVent Balloon to Strengthen ENT Business
by Zacks Equity Research
Medtronic's (MDT) Nuvent balloons are one-time use devices featuring a flexible balloon section that allows customized placement based on patient anatomy.
Inogen (INGN) Stock Surges 16.5% Despite Q4 Earnings Miss
by Zacks Equity Research
Inogen's (INGN) fourth-quarter results benefit from higher revenues across the majority of its geographical segments.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on continued growth in its consumer-centric digital solutions.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Zacks.com featured highlights include: ConocoPhillips, Tyson Foods, Inc., AMN Healthcare Services, Inc., WESCO International, Inc. and Capri Holdings Ltd
by Zacks Equity Research
ConocoPhillips, Tyson Foods, Inc., AMN Healthcare Services, Inc., WESCO International, Inc. and Capri Holdings Ltd are highlighted in this Screen of the Week article.
Looking for a Growth Stock? 3 Reasons Why AMN Healthcare (AMN) is a Solid Choice
by Zacks Equity Research
AMN Healthcare (AMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
OPKO Health's (OPK) Q4 Earnings Miss Estimates, Revenues Top
by Zacks Equity Research
OPKO Health's (OPK) fourth-quarter results benefit from continued strength in its Pharmaceuticals segment.
Merit Medical's (MMSI) Q4 Earnings, Revenues Top Estimates
by Zacks Equity Research
Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its Cardiovascular unit.
Here's Why You Should Invest In Henry Schein (HSIC) Now
by Zacks Equity Research
Investors are optimistic about Henry Schein's (HSIC) favorable dental business trends and bullish fourth-quarter 2021 performance.
Thermo Fisher (TMO) Extends Collaboration With Moderna
by Zacks Equity Research
Thermo Fisher (TMO) continues to be a trusted partner of Moderna, bringing a wide range of products and services enabling Moderna to deliver innovative medicines at an extraordinary speed and scale.
Use Relative Price Strength to Survive the Market Turmoil
by Nilanjan Choudhury
ConocoPhillips (COP), Tyson Foods (TSN), AMN Healthcare (AMN), WESCO International (WCC) and Capri Holdings (CPRI) are five stocks with explosive relative price strength.
Thermo Fisher (TMO) COVID Test Sales Grow, FX Woes Persist
by Zacks Equity Research
Thermo Fisher's (TMO) strong pandemic response stance enables it to accelerate its growth strategy, and bump up investments, which encourages it to raise the 2022 core organic growth guidance.
Allscripts' (MDRX) Q4 Earnings Beat Estimates, Margins Up
by Debanjana Dey
Allscripts' (MDRX) robust Q4 results demonstrate strength in both segments.
Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates
by Zacks Equity Research
Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q4 due to soft geographical performances.
Earnings Estimates Rising for AMN Healthcare (AMN): Will It Gain?
by Zacks Equity Research
AMN Healthcare (AMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Avanos Medical (AVNS) Q4 Earnings, Revenues Top Estimates
by Zacks Equity Research
Avanos Medical's (AVNS) fourth-quarter 2021 results gain from strength in the chronic care segment.
AMN Healthcare Services and The Gap have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
AMN Healthcare Services and The Gap have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: AMN Healthcare (AMN)
by Tracey Ryniec
Healthcare solutions is red-hot in 2022.